United Guardian UG
NASDAQ UG
$7.11 -0.01 (-0.14%)
As of: Sep 9, 2026 · 12:33 PM EDT

United Guardian (UG) Cash from Financing Activities (2010 - 2026)

United Guardian's (UG) quarterly Cash from Financing Activities came in at -$1.1 million in Q1 2026, up 28.48% year-over-year from -$894965.2 in Q1 2025, and little changed quarter-over-quarter from -$1.1 million in Q3 2025.

Analysis

United Guardian (UG) Cash from Financing Activities (2010 - 2026) Analysis & Trends

United Guardian has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$1.1 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 28.48% year-over-year to -$1.1 million; the TTM figure through Jun 2026 stood at -$2.3 million (up 28.75% YoY), while the FY2025 annual figure was -$2.8 million, changed 0.38% from the prior year.
  • Cash from Financing Activities came in at -$1.1 million for Q1 2026 at United Guardian, roughly flat from -$1.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of -$10290.0 in Q2 2025 to a low of -$1.6 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is -$1.1 million, with a median of -$1.1 million recorded in 2025.
  • Year-over-year, Cash from Financing Activities jumped 52.3% in 2022 and tumbled 250.0% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$1.4 million in 2022, then soared by 67.74% to -$459387.0 in 2023, then plunged by 250.0% to -$1.6 million in 2024, then grew by 28.57% to -$1.1 million in 2025, then slipped by 0.12% to -$1.1 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$1.1 million in Q1 2026, -$1.1 million in Q3 2025, and -$10290.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn -8.78 Bn
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn -5.05 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn -2.02 Bn
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn -3.66 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -2.10 Bn
7 Revolution Medicines 44.38 Bn 44.38 Bn - 2.42 Bn
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn 65.46 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 122.40 Mn
10 United Guardian 32.67 Mn 23.07 Mn 1.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.15 Mn
Sep 30, 2025 -1.15 Mn
Jun 30, 2025 -10,290.00
Mar 31, 2025 -1.61 Mn
Sep 30, 2024 -1.61 Mn
Mar 31, 2024 -1.15 Mn
Sep 30, 2023 -459,387.00
Dec 31, 2022 -1.42 Mn
Dec 31, 2021 -2.99 Mn
Dec 31, 2020 -1.65 Mn
Dec 31, 2019 -2.52 Mn
Dec 31, 2018 -2.52 Mn
Dec 31, 2017 -4.58 Mn
Dec 31, 2016 -1.83 Mn
Dec 31, 2015 -2.17 Mn
Dec 31, 2014 -1.47 Mn
Dec 31, 2013 -2.30 Mn
Dec 31, 2012 -4.32 Mn
Dec 31, 2011 -2.02 Mn
Dec 31, 2010 -1.52 Mn